Synopsis

Source of validity: Scientific
Rating (out of 5): 2

N-Acetyl Carnosine (NAC) is primarily researched for its potential use in supporting eye health, particularly in the management of cataracts. The scientific interest centers on NAC's antioxidant properties. Carnosine, the parent compound, is a naturally occurring dipeptide in the body, and its acetylated form (NAC) is believed to penetrate the cornea more effectively when used in eye drops.

A handful of small clinical trials, mostly conducted in Russia and Eastern Europe, have suggested that NAC eye drops may slow the progression of cataracts and improve lens clarity in older adults. These studies, however, often suffer from limitations such as small sample sizes, short duration, and lack of independent replication. There is some evidence from animal models indicating that NAC can reduce oxidative damage in the lens, which is a key contributor to cataract development.

Despite these findings, major ophthalmological organizations (such as the American Academy of Ophthalmology) do not currently endorse NAC as a standard treatment, citing insufficient high-quality, large-scale randomized controlled trials. As a result, while the existing evidence is intriguing and suggests a possible benefit, it is not robust enough to fully validate NAC for routine clinical use in eye health.

In summary, NAC has some scientific backing for eye support, mainly as an antioxidant in cataract management, but the evidence is limited and not yet definitive.

More about N-Acetyl Carnosine
More about Eyes

Other ingredients that support Eyes

Other body systems supported by N-Acetyl Carnosine

Products containing N-Acetyl Carnosine